Artigos de revistas sobre o tema "Kappa free light chains"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores artigos de revistas para estudos sobre o assunto "Kappa free light chains".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Schwenkenbecher, Philipp, Franz Konen, Ulrich Wurster, Konstantin Jendretzky, Stefan Gingele, Kurt-Wolfram Sühs, Refik Pul, Torsten Witte, Martin Stangel e Thomas Skripuletz. "The Persisting Significance of Oligoclonal Bands in the Dawning Era of Kappa Free Light Chains for the Diagnosis of Multiple Sclerosis". International Journal of Molecular Sciences 19, n.º 12 (29 de novembro de 2018): 3796. http://dx.doi.org/10.3390/ijms19123796.
Texto completo da fonteDul, J. L., S. Aviel, J. Melnick e Y. Argon. "Ig light chains are secreted predominantly as monomers." Journal of Immunology 157, n.º 7 (1 de outubro de 1996): 2969–75. http://dx.doi.org/10.4049/jimmunol.157.7.2969.
Texto completo da fonteAmbrosino, D. M., M. V. Kanchana, N. R. Delaney e R. W. Finberg. "Human B cells secrete predominantly lambda L chains in the absence of H chain expression." Journal of Immunology 146, n.º 2 (15 de janeiro de 1991): 599–602. http://dx.doi.org/10.4049/jimmunol.146.2.599.
Texto completo da fonteRichter, Alex G., Stephen Harding, Aarnoud Huissoon, Mark Drayson e Guy Pratt. "Multiple Myeloma with Monoclonal Free IgG3 Heavy Chains and Free Kappa Light Chains". Acta Haematologica 123, n.º 3 (2010): 158–61. http://dx.doi.org/10.1159/000292899.
Texto completo da fonteArneth, Borros, e Jörg Kraus. "The Use of Kappa Free Light Chains to Diagnose Multiple Sclerosis". Medicina 58, n.º 11 (24 de outubro de 2022): 1512. http://dx.doi.org/10.3390/medicina58111512.
Texto completo da fonteRamsden, DB. "Multiple sclerosis: assay of free immunoglobulin light chains". Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 54, n.º 1 (28 de setembro de 2016): 5–13. http://dx.doi.org/10.1177/0004563216652175.
Texto completo da fonteVinayek, Namita, Goetz H. Kloecker e Beth C. Riley. "Multiple Myeloma with Secretory and Non-Secretory Biclonal Gammopathy". Blood 118, n.º 21 (18 de novembro de 2011): 5092. http://dx.doi.org/10.1182/blood.v118.21.5092.5092.
Texto completo da fonteAbbi, Kamal Kant Singh, Guido J. Tricot, Margarida Silverman, Kalyan Nadiminti e Matthew Krasowski. "Potential Pitfalls of Serum Free Light Chain Analysis to Assess Treatment Response for Multiple Myeloma". Blood 126, n.º 23 (3 de dezembro de 2015): 5308. http://dx.doi.org/10.1182/blood.v126.23.5308.5308.
Texto completo da fonteRudick, Richard A., Adam Pallant, Jean M. Bidlack e Robert M. Herndon. "Free kappa light chains in multiple sclerosis spinal fluid". Annals of Neurology 20, n.º 1 (julho de 1986): 63–69. http://dx.doi.org/10.1002/ana.410200111.
Texto completo da fontePratt, G., A. Richter, A. Huisoon, M. Drayson e S. Harding. "A177 Multiple Myeloma with Monoclonal Free IgG3 Heavy Chains and Free Kappa Light Chains". Clinical Lymphoma and Myeloma 9 (fevereiro de 2009): S30—S31. http://dx.doi.org/10.1016/s1557-9190(11)70494-2.
Texto completo da fonteLee, Won S., e Gurmukh Singh. "Serum Free Light Chain Assay in Monoclonal Gammopathic Manifestations". Laboratory Medicine 50, n.º 4 (8 de abril de 2019): 381–89. http://dx.doi.org/10.1093/labmed/lmz007.
Texto completo da fonteRichter, Alex G., Stephen Harding, Steve Rimmer, Guy Pratt, Aarnoud Huissoon e Mark Drayson. "Biclonal Multiple Myeloma with Monoclonal Free IgG3 Heavy Chain and kappa Free Light Chains." Blood 110, n.º 11 (16 de novembro de 2007): 4768. http://dx.doi.org/10.1182/blood.v110.11.4768.4768.
Texto completo da fonteMehta, P. D., S. D. Cook, P. K. Coyle, R. A. Troiano, C. S. Constantinescu e A. M. Rostami. "Free light chains in multiple sclerosis urine". Multiple Sclerosis Journal 4, n.º 3 (junho de 1998): 254–56. http://dx.doi.org/10.1177/135245859800400331.
Texto completo da fonteKaplan, Batia, Esther Ganelin-Cohen, Sizilia Golderman e Avi Livneh. "Diagnostic utility of kappa free light chains in multiple sclerosis". Expert Review of Molecular Diagnostics 19, n.º 4 (27 de fevereiro de 2019): 277–79. http://dx.doi.org/10.1080/14737159.2019.1586535.
Texto completo da fonteMarkowitz, Glen S., Raymond S. Flis, Neeraja Kambham e Vivette D. D'Agati. "Fanconi syndrome with free kappa light chains in the urine". American Journal of Kidney Diseases 35, n.º 4 (abril de 2000): 777–81. http://dx.doi.org/10.1016/s0272-6386(00)70032-1.
Texto completo da fonteYap, Clementine YF, Pey Wah Wong e Tar Choon Aw. "Free Kappa and Lambda Light Chains in Plasma Cell Dyscrasias". Proceedings of Singapore Healthcare 20, n.º 1 (março de 2011): 64–66. http://dx.doi.org/10.1177/201010581102000111.
Texto completo da fonteSingh, Gurmukh. "Concentrations of Serum Free Light Chains in Kappa and Lambda Lesions in Light-Chain Myelomas". Laboratory Medicine 50, n.º 2 (13 de novembro de 2018): 189–93. http://dx.doi.org/10.1093/labmed/lmy067.
Texto completo da fonteAugustson, Bradley M., Steven D. Reid, Graham P. Mead, Mark T. Drayson, J. Anthony Child e Arthur R. Bradwell. "Serum Free Light Chain Levels in Asymptomatic Myeloma." Blood 104, n.º 11 (16 de novembro de 2004): 4880. http://dx.doi.org/10.1182/blood.v104.11.4880.4880.
Texto completo da fonteLevinson, Stanley S. "kappa/lambda index for confirming urinary free light chain in amyloidosis AL and other plasma cell dyscrasias". Clinical Chemistry 37, n.º 6 (1 de junho de 1991): 1122–26. http://dx.doi.org/10.1093/clinchem/37.6.1122.
Texto completo da fonteŠegulja, Dragana, Danica Matišić, Karmela Barišić e Dunja Rogić. "Verification study of free light chains assays on reagent-optimized analysers". Biochemia medica 29, n.º 3 (15 de outubro de 2019): 579–86. http://dx.doi.org/10.11613/bm.2019.030709.
Texto completo da fonteSingh, Gurmukh. "Serum and Urine Protein Electrophoresis and Serum-Free Light Chain Assays in the Diagnosis and Monitoring of Monoclonal Gammopathies". Journal of Applied Laboratory Medicine 5, n.º 6 (1 de novembro de 2020): 1358–71. http://dx.doi.org/10.1093/jalm/jfaa153.
Texto completo da fonteSaadeh, Ruba S., Sandra C. Bryant, Andrew McKeon, Brian Weinshenker, David L. Murray, Sean J. Pittock e Maria Alice V. Willrich. "CSF Kappa Free Light Chains: Cutoff Validation for Diagnosing Multiple Sclerosis". Mayo Clinic Proceedings 97, n.º 4 (abril de 2022): 738–51. http://dx.doi.org/10.1016/j.mayocp.2021.09.014.
Texto completo da fonteSüße, Marie, Fritz Feistner, Matthias Grothe, Matthias Nauck, Alexander Dressel e Malte Johannes Hannich. "Free light chains kappa can differentiate between myelitis and noninflammatory myelopathy". Neurology - Neuroimmunology Neuroinflammation 7, n.º 6 (18 de setembro de 2020): e892. http://dx.doi.org/10.1212/nxi.0000000000000892.
Texto completo da fonteBayart, J. L., N. Muls e V. van Pesch. "Free Kappa light chains in neuroinflammatory disorders: Complement rather than substitute?" Acta Neurologica Scandinavica 138, n.º 4 (13 de junho de 2018): 352–58. http://dx.doi.org/10.1111/ane.12969.
Texto completo da fonteČabarkapa, Velibor, Zoran Stošić, Mirjana Đerić, Ljiljana Vučurević-Ristić e Mirjana Drljača. "The Importance of Free Light Chains of Immunoglobulins Determination in Serum". Journal of Medical Biochemistry 26, n.º 4 (1 de dezembro de 2007): 269–73. http://dx.doi.org/10.2478/v10011-007-0032-6.
Texto completo da fonteTreger, Rebecca, Kathleen Hutchinson, Andrew Bryan e Chihiro Morishima. "Lambda monoclonal free light chain abnormalities detected by a serum immunofixation electrophoresis assay are underrepresented by quantitative serum free light chain results". American Journal of Clinical Pathology 156, Supplement_1 (1 de outubro de 2021): S13—S14. http://dx.doi.org/10.1093/ajcp/aqab189.023.
Texto completo da fonteLevinson, S. S., e D. F. Keren. "Free light chains of immunoglobulins: clinical laboratory analysis". Clinical Chemistry 40, n.º 10 (1 de outubro de 1994): 1869–78. http://dx.doi.org/10.1093/clinchem/40.10.1869.
Texto completo da fonteSidana, Surbhi, Lisa Rybicki, Frederic J. Reu e Thomas Daly. "High Serum Free Kappa Chains Are Frequently Missed By Serum Immunofixation". Blood 124, n.º 21 (6 de dezembro de 2014): 5708. http://dx.doi.org/10.1182/blood.v124.21.5708.5708.
Texto completo da fonteEinarsson Long, Thorir, Sæmundur Rögnvaldsson, Sigrun Thorsteinsdottir, Ingigerdur Sverrisdottir, Elias Eythorsson, Olafur Indridason, Runolfur Palsson et al. "Revised Definition of Free Light Chains in Serum and Light Chain Monoclonal Gammopathy of Undetermined Significance: Results of the Istopmm Study". Blood 142, Supplement 1 (28 de novembro de 2023): 535. http://dx.doi.org/10.1182/blood-2023-188547.
Texto completo da fonteZeldenrust, Steven R., Ellen W. Blanco e Karl A. Nath. "Amyloidogenic lambda Light Chain Renal Toxicity: Oxidative Stress Implicated." Blood 110, n.º 11 (16 de novembro de 2007): 3531. http://dx.doi.org/10.1182/blood.v110.11.3531.3531.
Texto completo da fonteBradwell, Arthur R., Jean Garbincius e Earle W. Holmes. "Serum Free Kappa to Free Lambda Ratios as an Adjunct to Serum Protein Electrophoresis for the Detection of Monoclonal Proteins in the Serum." Blood 104, n.º 11 (16 de novembro de 2004): 4856. http://dx.doi.org/10.1182/blood.v104.11.4856.4856.
Texto completo da fonteMoesbauer, Ulrike, Heike Schieder, Helmut Renges, Francis Ayuk, Axel Zander e Nicolaus Kröger. "Serum Free Light Chain [FLC] Assay in Multiple Myeloma Patients Who Achieved Negative Immunofixation after Allogeneic Stem Cell Transplantation." Blood 106, n.º 11 (16 de novembro de 2005): 2023. http://dx.doi.org/10.1182/blood.v106.11.2023.2023.
Texto completo da fonteLong, Thorir E., Olafur S. Indridason, Runolfur Palsson, Stephen Harding, Ola Landgren e Sigurdur Y. Kristinsson. "The Effect of Kidney Function on Reference Intervals of Serum-Free Light Chains and Free Light Chain Kappa/Lambda Ratio". Journal of the American Society of Nephrology 32, n.º 10S (outubro de 2021): 743. http://dx.doi.org/10.1681/asn.20213210s1743b.
Texto completo da fonteRudick, RA, SV Medendorp, M. Namey, S. Boyle e J. Fischer. "Multiple sclerosis progression in a natural history study: Predictive value of cerebrospinal fluid free kappa light chains". Multiple Sclerosis Journal 1, n.º 3 (novembro de 1995): 150–55. http://dx.doi.org/10.1177/135245859500100303.
Texto completo da fonteHess, P. P., W. Mastropaolo, G. D. Thompson e S. S. Levinson. "Interference of polyclonal free light chains with identification of Bence Jones proteins". Clinical Chemistry 39, n.º 8 (1 de agosto de 1993): 1734–38. http://dx.doi.org/10.1093/clinchem/39.8.1734.
Texto completo da fonteGanta, Nagapratap, Varsha Gupta, Fnu Anamika, Akshit Chitkara, Sheilabi Seeburun e Ruchi Bhatt. "Lymphoplasmacytic Lymphoma: An Atypical Presentation with IgG Monoclonal Gammopathy". Blood 142, Supplement 1 (28 de novembro de 2023): 4425. http://dx.doi.org/10.1182/blood-2023-191167.
Texto completo da fonteNakaki, T., R. J. Deans e A. S. Lee. "Enhanced transcription of the 78,000-dalton glucose-regulated protein (GRP78) gene and association of GRP78 with immunoglobulin light chains in a nonsecreting B-cell myeloma line (NS-1)". Molecular and Cellular Biology 9, n.º 5 (maio de 1989): 2233–38. http://dx.doi.org/10.1128/mcb.9.5.2233-2238.1989.
Texto completo da fonteNakaki, T., R. J. Deans e A. S. Lee. "Enhanced transcription of the 78,000-dalton glucose-regulated protein (GRP78) gene and association of GRP78 with immunoglobulin light chains in a nonsecreting B-cell myeloma line (NS-1)." Molecular and Cellular Biology 9, n.º 5 (maio de 1989): 2233–38. http://dx.doi.org/10.1128/mcb.9.5.2233.
Texto completo da fonteBerek, Klaus, Gabriel Bsteh, Michael Auer, Franziska Di Pauli, Astrid Grams, Dejan Milosavljevic, Paulina Poskaite et al. "Kappa-Free Light Chains in CSF Predict Early Multiple Sclerosis Disease Activity". Neurology - Neuroimmunology Neuroinflammation 8, n.º 4 (28 de maio de 2021): e1005. http://dx.doi.org/10.1212/nxi.0000000000001005.
Texto completo da fontePresslauer, Stefan, Dejan Milosavljevic, Wolfgang Huebl, Silvia Parigger, Gabriele Schneider-Koch e Thomas Bruecke. "Kappa Free Light Chains: Diagnostic and Prognostic Relevance in MS and CIS". PLoS ONE 9, n.º 2 (25 de fevereiro de 2014): e89945. http://dx.doi.org/10.1371/journal.pone.0089945.
Texto completo da fonteVecchio, D., I. Crespi, E. Virgilio, P. Naldi, M. P. Campisi, R. Serino, U. Dianzani, G. Bellomo, R. Cantello e C. Comi. "Kappa free light chains could predict early disease course in multiple sclerosis". Multiple Sclerosis and Related Disorders 30 (maio de 2019): 81–84. http://dx.doi.org/10.1016/j.msard.2019.02.001.
Texto completo da fonteFong, S., P. P. Chen, T. A. Gilbertson, R. I. Fox, J. H. Vaughan e D. A. Carson. "Structural similarities in the kappa light chains of human rheumatoid factor paraproteins and serum immunoglobulins bearing a cross-reactive idiotype." Journal of Immunology 135, n.º 3 (1 de setembro de 1985): 1955–60. http://dx.doi.org/10.4049/jimmunol.135.3.1955.
Texto completo da fonteSarris, Katerina, Dimitrios Maltezas, Efstathios Koulieris, Vassiliki Bartzis, Tatiana Tzenou, Sotirios Sachanas, Eftychia Nikolaou et al. "Prognostic Significance of Serum Free Light Chains in Chronic Lymphocytic Leukemia". Advances in Hematology 2013 (2013): 1–7. http://dx.doi.org/10.1155/2013/359071.
Texto completo da fonteShammo, Jamile M., Agne Paner, MV Ramana Reddy, Rachel L. Mitchell e Parameswaran Venugopal. "A Striking Reduction of Monoclonal Protein in a Patient with Concurrent Plasma Cell Dyscrasia and CMML-2, after Treatment with Rigosertib (01910.Na)". Blood 126, n.º 23 (3 de dezembro de 2015): 5362. http://dx.doi.org/10.1182/blood.v126.23.5362.5362.
Texto completo da fonteLee, Won Sok, e Gurmukh Singh. "Serum Free Light Chains in Neoplastic Monoclonal Gammopathies: Relative Under-Detection of Lambda Dominant Kappa/Lambda Ratio, and Underproduction of Free Lambda Light Chains, as Compared to Kappa Light Chains, in Patients With Neoplastic Monoclonal Gammopathies". Journal of Clinical Medicine Research 10, n.º 7 (2018): 562–69. http://dx.doi.org/10.14740/jocmr3383w.
Texto completo da fonteGiussani, Marta, Chiara Maura Ciniselli, Alessandra Macciotta, Rossella Panella, Paolo Verderio, Chiara Bonini e Daniele Morelli. "κ and λ urine free light chains: a new method for quantification". Tumori Journal 106, n.º 6 (20 de janeiro de 2020): 457–63. http://dx.doi.org/10.1177/0300891619898533.
Texto completo da fonteLee, Won, e Gurmukh Singh. "Serum Free Light Chains in Neoplastic Monoclonal Gammopathies: Relative Underproduction and Underdetection of Free Lambda Light Chains, as Compared to Kappa Light Chains, in Patients With Neoplastic Monoclonal Gammopathies". American Journal of Clinical Pathology 150, suppl_1 (21 de setembro de 2018): S145—S146. http://dx.doi.org/10.1093/ajcp/aqy112.346.
Texto completo da fonteVavrova, Jaroslava, Bedrich Friedecky, Milos Tichy, Magdalena Holeckova, Vladimir Maisnar e Roman Hajek. "The Evaluation of Light Chains USING ELISA Method". Blood 112, n.º 11 (16 de novembro de 2008): 5147. http://dx.doi.org/10.1182/blood.v112.11.5147.5147.
Texto completo da fonteЧурко, А. А., e А. Ш. Румянцев. "Free Light Chains of Immunoglobulins as a Biomarker of Glomerulopathies". Juvenis Scientia, n.º 3 (30 de junho de 2023): 42–50. http://dx.doi.org/10.32415/jscientia_2023_9_3_42-50.
Texto completo da fonteDuell, Frida, Björn Evertsson, Faiez Al Nimer, Åsa Sandin, Daniel Olsson, Tomas Olsson, Mohsen Khademi, Max Albert Hietala, Fredrik Piehl e Magnus Hansson. "Diagnostic accuracy of intrathecal kappa free light chains compared with OCBs in MS". Neurology - Neuroimmunology Neuroinflammation 7, n.º 4 (11 de junho de 2020): e775. http://dx.doi.org/10.1212/nxi.0000000000000775.
Texto completo da fonte